Absolute Bioavailability and Disposition of Lanthanum in Healthy Human Subjects Administered Lanthanum Carbonate

This publication has 23 references indexed in Scilit:

• Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate
  Nephron Clinical Practice, 2005
• Assessment of effects of lanthanum carbonate with and without phosphate supplementation on bone mineralization in uremic rats
  Clinical Nephrology, 2005
• Evaluation of the potential genotoxicity of the phosphate binder lanthanum carbonate
  Mutagenesis, 2005
• Does the Phosphate Binder Lanthanum Carbonate Affect Bone in Rats with Chronic Renal Failure?
  Journal of the American Society of Nephrology, 2004
• Bile acid binding to sevelamer HCl
  Kidney International, 2002
• Determination of the binding parameter constants of Renagel® capsules and tablets utilizing the Langmuir approximation at various pH by ion chromatography
  Journal of Pharmaceutical and Biomedical Analysis, 2002
• Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management
  American Journal of Kidney Diseases, 2000
• Coronary-Artery Calcification in Young Adults with End-Stage Renal Disease Who Are Undergoing Dialysis
  New England Journal of Medicine, 2000
• Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
  American Journal of Kidney Diseases, 1998
• Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?
  Nephrology Dialysis Transplantation, 1998